{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:25:27Z","timestamp":1787505927691,"version":"build-2736575974"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973625"],"award-info":[{"award-number":["81973625"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFC1316003"],"award-info":[{"award-number":["2019YFC1316003"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bcp.2026.117976","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:04:29Z","timestamp":1776233069000},"page":"117976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["Bufalin reverses oxaliplatin resistance in gastric cancer by targeting YBX1 to suppress glycolysis"],"prefix":"10.1016","volume":"250","author":[{"given":"Xiaotong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengyou","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zean","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongbiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2026.117976_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer","volume":"74","author":"Bray","year":"2024","journal-title":"J. Clin."},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-024-01654-2","article-title":"Helicobacter pylori and gastric cancer: mechanisms and new perspectives","volume":"18","author":"Duan","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2026.117976_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117068","article-title":"Regulatory mechanisms and potential therapeutic targets in precancerous lesions of gastric cancer: a comprehensive review","volume":"177","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.117976_b0020","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.12659\/MSM.916475","article-title":"Recent advances in the Surgical Treatment of Advanced Gastric Cancer: a Review","volume":"25","author":"Tan","year":"2019","journal-title":"Med. Sci. Monit."},{"issue":"6","key":"10.1016\/j.bcp.2026.117976_b0025","first-page":"619","article-title":"Atezolizumab and Trastuzumab Plus Chemotherapy for ERBB2-positive locally Advanced Resectable Gastric Cancer: a Randomized Clinical Trial JAMA","volume":"11","author":"Peng","year":"2025","journal-title":"Oncol"},{"issue":"6","key":"10.1016\/j.bcp.2026.117976_b0030","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S1470-2045(25)00130-5","article-title":"TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trial","volume":"26","author":"Zaanan","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bcp.2026.117976_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116310","article-title":"Deciphering drug resistance in gastric cancer: potential mechanisms and future perspectives","volume":"173","author":"Liu","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.bcp.2026.117976_b0040","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s11655-024-3708-6","article-title":"Chemical Composition, Pharmacological Effects and Clinical applications of Cinobufacini","volume":"30","author":"Zuo","year":"2024","journal-title":"Chin. J. Integr. Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.117976_b0045","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jep.2011.12.018","article-title":"Bufothionine, a possible effective component in cinobufocini injection for hepatocellular carcinoma","volume":"141","author":"Xie","year":"2012","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0050","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13020-025-01179-x","article-title":"Explore the potential mechanism of Huachansu injection against osteosarcoma via metabolomics, network pharmacology and bioinformatics","volume":"20","author":"Meng","year":"2025","journal-title":"Chin. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.117976_b0055","doi-asserted-by":"crossref","first-page":"889","DOI":"10.7150\/jca.91301","article-title":"Effectiveness and Safety of Chinese Herbal Injections combined with SOX Chemotherapy Regimens for Advanced Gastric Cancer: a Bayesian Network Meta-Analysis","volume":"15","author":"Bu","year":"2024","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12943-024-02213-6","article-title":"Tailoring traditional chinese medicine in cancer therapy","volume":"24","author":"Li","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.117976_b0065","doi-asserted-by":"crossref","unstructured":"C.S. Cheng, J. Wang, J. Chen, K.T. Kuo, J. Tang, H. Gao, et al. New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin Cancer Cell Int., 19 (2019), p. 92.","DOI":"10.1186\/s12935-019-0806-1"},{"key":"10.1016\/j.bcp.2026.117976_b0070","doi-asserted-by":"crossref","unstructured":"S. Wu, X. Wu, Q. Wang, Z. Chen, L. Li, H. Chen, et al. Bufalin induces ferroptosis by modulating the 2,4-dienoyl-CoA reductase (DECR1)-SLC7A11 axis in breast cancer Phytomedicine, 135 (2024), p. 156130.","DOI":"10.1016\/j.phymed.2024.156130"},{"issue":"5\u20136","key":"10.1016\/j.bcp.2026.117976_b0075","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10495-023-01930-5","article-title":"Mechanism of bufalin inhibition of colon cancer liver metastasis by regulating M2-type polarization of Kupffer cells induced by highly metastatic colon cancer cells","volume":"29","author":"Tang","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcp.2026.117976_b0080","doi-asserted-by":"crossref","unstructured":"X. Zhang, X. Lu, J. Shi, Y. Li, Y. Li, R. Tao, et al. Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1\/\u03b2-catenin signaling Phytomedicine, 126 (2024), p. 155395.","DOI":"10.1016\/j.phymed.2024.155395"},{"key":"10.1016\/j.bcp.2026.117976_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106777","article-title":"Molecular and metabolic mechanisms of bufalin against lung adenocarcinoma: New and comprehensive evidences from network pharmacology, metabolomics and molecular biology experiment","volume":"157","author":"Shi","year":"2023","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12935-023-03196-y","article-title":"ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy","volume":"24","author":"Soumoy","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"5","key":"10.1016\/j.bcp.2026.117976_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28052231","article-title":"Bufalin-Mediated Regulation of Cell Signaling Pathways in Different Cancers: Spotlight on JAK\/STAT, Wnt\/\u03b2-Catenin, mTOR, TRAIL\/TRAIL-R, and Non-Coding RNAs","volume":"28","author":"Farooqi","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2026.117976_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150440","article-title":"Bufalin: A promising therapeutic drug against the cisplatin-resistance of ovarian cancer by targeting the USP36\/c-Myc axis","volume":"733","author":"Li","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2026.117976_b0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00432-025-06124-x","article-title":"Bufalin targets the SRC-3\/c-Myc pathway in chemoresistant cells to regulate metastasis induced by chemoresistance in colorectal cancer","volume":"151","author":"Chen","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13046-021-02220-1","article-title":"AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma","volume":"41","author":"Gu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117976_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101005","article-title":"Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer","volume":"71","author":"Zhang","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bcp.2026.117976_b0120","doi-asserted-by":"crossref","unstructured":"A.M. Otto Warburg effect(s)-a biographical sketch of Otto Warburg and his impacts on tumor metabolism Cancer Metab., 4 (2016), p. 5.","DOI":"10.1186\/s40170-016-0145-9"},{"issue":"3","key":"10.1016\/j.bcp.2026.117976_b0125","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","article-title":"Targeting the Warburg effect: a revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer","volume":"14","author":"Liao","year":"2024","journal-title":"Acta pharmaceutica Sinica. B"},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbcan.2016.12.004","article-title":"Linking metabolic reprogramming to therapy resistance in cancer","volume":"1868","author":"Morandi","year":"2017","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.117976_b0135","article-title":"The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.bcp.2026.117976_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24097771","article-title":"Metabolic Effects of New Glucose Transporter (GLUT-1) and Lactate Dehydrogenase-a (LDH-A) Inhibitors against Chemoresistant Malignant Mesothelioma","volume":"24","author":"Franczak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0145","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40170-023-00309-z","article-title":"Long non-coding RNA CCHE1 modulates LDHA-mediated glycolysis and confers chemoresistance to melanoma cells","volume":"11","author":"Ding","year":"2023","journal-title":"Cancer Metab."},{"issue":"19","key":"10.1016\/j.bcp.2026.117976_b0150","doi-asserted-by":"crossref","first-page":"19807","DOI":"10.1002\/cam4.6552","article-title":"TRAF6 promotes chemoresistance to paclitaxel of triple negative breast cancer via regulating PKM2-mediated glycolysis","volume":"12","author":"Xu","year":"2023","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.117976_b0155","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41419-022-04727-7","article-title":"TRIM46 activates AKT\/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells","volume":"13","author":"Tantai","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4172\/1747-0862.1000005","article-title":"Significance of the Y-box proteins in human cancers","volume":"1","author":"Matsumoto","year":"2005","journal-title":"J. Mol. Genet. Med."},{"issue":"11","key":"10.1016\/j.bcp.2026.117976_b0165","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/s41417-023-00657-4","article-title":"LINC00665 activating Wnt3a\/\u03b2-catenin signaling by bond with YBX1 promotes gastric cancer proliferation and metastasis","volume":"30","author":"Wang","year":"2023","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0170","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/wrna.1200","article-title":"YB-1 protein: functions and regulation","volume":"5","author":"Lyabin","year":"2014","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.bcp.2026.117976_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2025.110322","article-title":"Diffuse large B-cell lymphoma cell-derived exosomal NSUN2 stabilizes PDL1 to promote tumor immune escape and M2 macrophage polarization in a YBX1-dependent manner","volume":"766","author":"Ling","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood.2020009676","article-title":"YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner","volume":"138","author":"Feng","year":"2021","journal-title":"Blood"},{"issue":"28","key":"10.1016\/j.bcp.2026.117976_b0185","doi-asserted-by":"crossref","first-page":"10998","DOI":"10.1074\/jbc.RA119.007545","article-title":"Crystal structure of a Y-box binding protein 1 (YB-1)-RNA complex reveals key features and residues interacting with RNA","volume":"294","author":"Yang","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"7836","key":"10.1016\/j.bcp.2026.117976_b0190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41586-020-2968-3","article-title":"Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms","volume":"588","author":"Jayavelu","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bcp.2026.117976_b0195","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.7150\/ijbs.91861","article-title":"Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the ROR\u03b1\/ECM1\/VEGFR2 signaling axis","volume":"20","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2026.117976_b0200","article-title":"Synergistic antitumor activity of 5-fluorouracil and atosiban against microsatellite stable colorectal cancer through restoring GATA3 Biochem","volume":"199","author":"Wang","year":"2022","journal-title":"Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0205","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mce.2009.07.007","article-title":"Identification and characterization of the hypoxia-responsive element in human stanniocalcin-1 gene","volume":"314","author":"Law","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117976_b0210","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12032-024-02528-w","article-title":"siRNA-based strategies to combat drug resistance in gastric cancer","volume":"41","author":"Khaleel","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bcp.2026.117976_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101125","article-title":"Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistance","volume":"77","author":"Dong","year":"2024","journal-title":"Drug Resist. Updat."},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s11658-024-00676-5","article-title":"Exosome-derived proteins in gastric cancer progression, drug resistance, and immune response Cell","volume":"29","author":"Wang","year":"2024","journal-title":"Mol. Biol. Lett."},{"key":"10.1016\/j.bcp.2026.117976_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107302","article-title":"Relationship between clonal evolution and drug resistance in bladder cancer: a genomic research review","volume":"206","author":"Tuo","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2026.117976_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101080","article-title":"Circumventing drug resistance in gastric cancer: a spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics","volume":"74","author":"Che","year":"2024","journal-title":"Drug Resist. Updat."},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30010003","article-title":"Resveratrol, Piceatannol, Curcumin, and Quercetin as Therapeutic Targets in Gastric Cancer-Mechanisms and Clinical Implications for Natural Products","volume":"30","author":"Warias","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2026.117976_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112178","article-title":"Metabolites from Bufo gargarizans (Cantor, 1842): a review of traditional uses, pharmacological activity, toxicity and quality control","volume":"246","author":"Zhan","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2026.117976_b0245","doi-asserted-by":"crossref","unstructured":"F. Qi, A. Li, Y. Inagaki, N. Kokudo, S. Tamura, M. Nakata, et al. Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor Int. Immunopharmacol., 11(3) (2011), pp. 342-9.","DOI":"10.1016\/j.intimp.2010.12.007"},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/CAD.0b013e3283160fd6","article-title":"PI3K\/Akt is involved in bufalin-induced apoptosis in gastric cancer cells","volume":"20","author":"Li","year":"2009","journal-title":"Anticancer Drugs"},{"issue":"9\u201310","key":"10.1016\/j.bcp.2026.117976_b0255","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1007\/s10495-023-01855-z","article-title":"Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K\/AKT\/mTOR signal pathway","volume":"28","author":"Chen","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcp.2026.117976_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","article-title":"How the Warburg effect supports aggressiveness and drug resistance of cancer cells?","volume":"38","author":"Icard","year":"2018","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bcp.2026.117976_b0265","doi-asserted-by":"crossref","unstructured":"H. Wang, Y. Zhang, Y. Tian, W. Yang, Y. Wang, H. Hou, et al. DNA-PK-Mediated Cytoplasmic DNA Sensing Stimulates Glycolysis to Promote Lung Squamous Cell Carcinoma Malignancy and Chemoresistance Cancer Res., 84(5) (2024), pp. 688-702.","DOI":"10.1158\/0008-5472.CAN-23-0744"},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-024-06014-9","article-title":"FOSL1 transcriptionally dictates the Warburg effect and enhances chemoresistance in triple-negative breast cancer","volume":"23","author":"Zhao","year":"2025","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.bcp.2026.117976_b0275","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.apsb.2025.03.041","article-title":"Targeting the JAK2-STAT3-UCHL3-ENO1 axis suppresses glycolysis and enhances the sensitivity to 5-FU chemotherapy in TP53-mutant colorectal cancer","volume":"15","author":"Xin","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.bcp.2026.117976_b0280","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.7150\/thno.102730","article-title":"DLGAP5 enhances bladder cancer chemoresistance by regulating glycolysis through MYC stabilization","volume":"15","author":"Deng","year":"2025","journal-title":"Theranostics"},{"issue":"Pt 3","key":"10.1016\/j.bcp.2026.117976_b0285","article-title":"GPRC5A modulates resistance to temozolomide in glioblastoma through glycolytic reprogramming","volume":"321","author":"Alafate","year":"2025","journal-title":"Int. J. Biol. Macromol.,"},{"issue":"7","key":"10.1016\/j.bcp.2026.117976_b0290","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/bies.10300","article-title":"The pleiotropic functions of the Y-box-binding protein, YB-1","volume":"25","author":"Kohno","year":"2003","journal-title":"Bioessays"},{"key":"10.1016\/j.bcp.2026.117976_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110073","article-title":"A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance Cell","volume":"85","author":"Alkrekshi","year":"2021","journal-title":"Signal"},{"issue":"2","key":"10.1016\/j.bcp.2026.117976_b0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020717","article-title":"Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic potential","volume":"25","author":"Dinh","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117976_b0305","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9992218","article-title":"Nucleolin Promotes Cisplatin Resistance in Cervical Cancer by the YB1-MDR1 Pathway","volume":"2021","author":"Ke","year":"2021","journal-title":"J. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117976_b0310","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ijrobp.2021.06.021","article-title":"Targeting the Y-box Binding Protein-1 Axis to Overcome Radiochemotherapy Resistance in Solid Tumors","volume":"111","author":"Lettau","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bcp.2026.117976_b0315","doi-asserted-by":"crossref","unstructured":"S. Ghatak, V.C. Hascall, R.R. Markwald, S. Misra FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells Int. J. Mol. Sci., 22(2) (2021).","DOI":"10.3390\/ijms22020753"},{"issue":"38","key":"10.1016\/j.bcp.2026.117976_b0320","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1038\/s41388-020-01409-6","article-title":"Enhanced YB1\/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma","volume":"39","author":"Ruan","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.117976_b0325","doi-asserted-by":"crossref","unstructured":"K. Schelch, D. Emminger, B. Zitta, T.G. Johnson, V. Kopatz, S. Eder, et al. Targeting YB-1 via entinostat enhances cisplatin sensitivity of pleural mesothelioma in vitro and in vivo Cancer Lett., 574 (2023), p. 216395.","DOI":"10.1016\/j.canlet.2023.216395"},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0330","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41389-022-00387-6","article-title":"SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1","volume":"11","author":"Gao","year":"2022","journal-title":"Oncogenesis"},{"issue":"39","key":"10.1016\/j.bcp.2026.117976_b0335","doi-asserted-by":"crossref","first-page":"65946","DOI":"10.18632\/oncotarget.19583","article-title":"YBX1 promotes tumor growth by elevating glycolysis in human bladder cancer","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.bcp.2026.117976_b0340","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70122","article-title":"Glucose-induced LINC01419 reprograms the glycolytic pathway by recruiting YBX1 to enhance PDK1 mRNA stability in hepatocellular carcinoma","volume":"14","author":"Liu","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.117976_b0345","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.bcp.2026.117976_b0350","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41419-023-06008-3","article-title":"THOC3 interacts with YBX1 to promote lung squamous cell carcinoma progression through PFKFB4 mRNA modification","volume":"14","author":"Yu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117976_b0355","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fendo.2020.00172","article-title":"New Insights into Physiological and Pathophysiological Functions of Stanniocalcin 2","volume":"11","author":"Joshi","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"14","key":"10.1016\/j.bcp.2026.117976_b0360","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.1111\/jcmm.15348","article-title":"Expression, function and clinical application of stanniocalcin-1 in cancer","volume":"24","author":"Zhao","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2026.117976_b0365","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.2147\/IJGM.S329723","article-title":"STC1 is a Novel Biomarker Associated with Immune Characteristics and Prognosis of Bladder Cancer","volume":"14","author":"Sun","year":"2021","journal-title":"Int. J. Gen. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0370","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12885-022-09449-9","article-title":"Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2026.117976_b0375","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/mt.2011.259","article-title":"Mesenchymal stromal cells protect cancer cells from ROS-induced apoptosis and enhance the Warburg effect by secreting STC1","volume":"20","author":"Ohkouchi","year":"2012","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2026.117976_b0380","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.4149\/neo_2022_220626N665","article-title":"Stanniocalcin1 knockdown induces ferroptosis and suppresses glycolysis in prostate cancer via the Nrf2 pathway","volume":"69","author":"Dai","year":"2022","journal-title":"Neoplasma"},{"issue":"1","key":"10.1016\/j.bcp.2026.117976_b0385","article-title":"Knockdown of Stanniocalcin-1 inhibits growth and glycolysis in oral squamous cell carcinoma cells","volume":"19","author":"Wang","year":"2024","journal-title":"Open Life Sci."},{"key":"10.1016\/j.bcp.2026.117976_b0390","article-title":"Predicting differences in Treatment Response and Survival Time of Lung Adenocarcinoma patients based on a Prognostic Risk Model of Glycolysis-Related Genes","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.bcp.2026.117976_b0395","article-title":"Glycolysis-based Genes are potential Biomarkers in Thyroid Cancer","volume":"11","author":"Xu","year":"2021","journal-title":"Front. Oncol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:13:21Z","timestamp":1780676001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226003096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":79,"alternative-id":["S0006295226003096"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117976","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bufalin reverses oxaliplatin resistance in gastric cancer by targeting YBX1 to suppress glycolysis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117976","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117976"}}